or
forgot password
  • cancer clinical trials in birmingham, AL

  • Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brain Tumor
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cushing's Disease
    A Study in Recurrent Glioblastoma (GB)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Glioblastoma
    Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
    Investigational Site Number 840010
    Birmingham, Alabama 35205
    Neoplasm Malignant
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Radiant Research

    Trial Locations
    Radiant Research
    Birmingham Heart Clinic
    Central Alabama Research
    Obesity, Overweight
    Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    The Kirklin Clinic at Acton Road
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Tumors Metastatic to Brain
    Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma
    Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
    Universeity of Alabama Cancer Center
    Birmingham, Alabama 35294
    Breast Neoplasms
    The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cholangiocarcinoma
    A Phase 2 Study Evaluating Ganetespib in Women With Metastatic HER2+ or Triple Negative Breast Cancer
    Synta Pharmaceuticals Investigative Site
    Birmingham, Alabama 35249
    Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer
    Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    High Risk Acute Myeloid Leukemia
    Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+ Metastatic Breast Cancer
    University of Alabama Comprehensive Cancer Center SC
    Birmingham, Alabama 35294
    Hormone Receptor Positive Breast Cancer
    Belimumab Assessment of Safety in SLE
    GSK Investigational Site
    Birmingham, Alabama 35209
    Systemic Lupus Erythematosus
    Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
    TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Non-HPV Locally Advanced Head and Neck Cancer
    Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
    University of Alabama at Birmingham (UAB)
    Birmingham, Alabama 35233
    Lupus Nephritis
    A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Hodgkin Disease
    Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Unspecified Childhood Solid Tumor, Protocol Specific
    Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
    University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Cutaneous T-Cell Lymphoma
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    University of Alabama Comprehensive Cancer Center University of Alabama (8)
    Birmingham, Alabama 35294
    CML
    Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Tuberous Sclerosis Complex
    A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brain Cancer
    ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Tuberous Sclerosis Complex
    Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Recurrent Adult Hodgkin Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma
    A Twelve Week Safety and Efficacy Study in Rosacea
    Radiant Research Inc.
    Birmingham, Alabama 35209
    Papulopustular Rosacea
    A Safety Study of SGN-CD19A for Leukemia and Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Burkitt Lymphoma, Precursor B-cell Lymphoblastic Leukemia-Lymphoma
    A Safety Study of SGN-CD19A for B-Cell Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor B-cell Lymphoblastic Leukemia-Lymphoma
    A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Non-small Cell Lung Cancer
    Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

    Birmingham, Alabama 35294
    Metastatic Cancer, Metastatic Pancreatic Cancer
    Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Castrate Resistent Prostate Cancer
    Photodynamic Therapy (PDT) Oncology Registry
    UAB-University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Lung Cancer, Esophageal
    Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
    Hazelrig-Salter Radiation Oncology Center
    Birmingham, Alabama 35249
    Prostate Cancer, Prostate Adenocarcinoma, Radiation Toxicity, Sexual Dysfunction
    LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease
    University of Alabama at Birmingham Sparks Center
    Birmingham, Alabama 35294
    Parkinson's Disease
    Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Hodgkin Disease
    Improving Energy Balance in Men With Prostate Cancer
    University of Alabama at Birmingham (UAB)
    Birmingham, Alabama 35233
    Prostate Cancer
    Risk Factors for Adult-Onset Brain Tumors
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brain Neoplasm, Primary, Brain Neoplasms, Malignant, Brain Neoplasms, Benign
    Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
    University of Alabama
    Birmingham, Alabama
    Granulomatosis With Polyangiitis, Microscopic Polyangiitis
    Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
    Site Reference ID/Investigator# 95563
    Birmingham, Alabama 35205
    Hidradenitis Suppurativa
    Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Sickle Cell Anemia
    Antifolate Effectiveness in Arthritis
    The University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Rheumatoid Arthritis, Adjuvant Arthritis